ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Ginkgo Bioworks Holdings Inc

Ginkgo Bioworks Holdings Inc (DNA)

8.25
-0.11
(-1.32%)
Closed April 15 3:00PM
8.20
-0.05
(-0.61%)
After Hours: 5:43PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
8.20
Bid
-
Ask
-
Volume
1,068,881
7.93 Day's Range 8.41
5.00 52 Week Range 45.20
Market Cap
Previous Close
8.36
Open
8.34
Last Trade
4
@
8.2884
Last Trade Time
Financial Volume
US$ 8,746,901
VWAP
8.1832
Average Volume (3m)
1,752,734
Shares Outstanding
58,033,600
Dividend Yield
-
PE Ratio
-0.88
Earnings Per Share (EPS)
-9.43
Revenue
227.04M
Net Profit
-547.03M

About Ginkgo Bioworks Holdings Inc

Ginkgo Bioworks Holdings Inc is building a platform to enable customers to program cells as easily to program computers. The company's platform is market agnostic and enables biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo Bioworks Holdings Inc is building a platform to enable customers to program cells as easily to program computers. The company's platform is market agnostic and enables biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals.

Sector
Biological Pds,ex Diagnstics
Industry
Blank Checks
Headquarters
Wilmington, Delaware, USA
Founded
2021
Ginkgo Bioworks Holdings Inc is listed in the Biological Pds,ex Diagnstics sector of the New York Stock Exchange with ticker DNA. The last closing price for Ginkgo Bioworks was US$8.36. Over the last year, Ginkgo Bioworks shares have traded in a share price range of US$ 5.00 to US$ 45.20.

Ginkgo Bioworks currently has 58,033,600 shares outstanding. The market capitalization of Ginkgo Bioworks is US$485.16 million. Ginkgo Bioworks has a price to earnings ratio (PE ratio) of -0.88.

DNA Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
11.420.58823529416.88.695.5721036487.33573332CS
40.324.060913705587.888.69515215556.75530319CS
12-2.77-25.250683682810.9716.85517527349.84369284CS
260.9513.10344827597.2516.85514896119.51256765CS
52-33-80.097087378641.245.252063932420.31473577CS
156-141.4-94.5187165775149.6196.452181566362.17334788CS
260-441.4-98.1761565836449.6634.5652032176783.86264636CS

DNA - Frequently Asked Questions (FAQ)

What is the current Ginkgo Bioworks share price?
The current share price of Ginkgo Bioworks is US$ 8.20
How many Ginkgo Bioworks shares are in issue?
Ginkgo Bioworks has 58,033,600 shares in issue
What is the market cap of Ginkgo Bioworks?
The market capitalisation of Ginkgo Bioworks is USD 485.16M
What is the 1 year trading range for Ginkgo Bioworks share price?
Ginkgo Bioworks has traded in the range of US$ 5.00 to US$ 45.20 during the past year
What is the PE ratio of Ginkgo Bioworks?
The price to earnings ratio of Ginkgo Bioworks is -0.88
What is the cash to sales ratio of Ginkgo Bioworks?
The cash to sales ratio of Ginkgo Bioworks is 2.11
What is the reporting currency for Ginkgo Bioworks?
Ginkgo Bioworks reports financial results in USD
What is the latest annual turnover for Ginkgo Bioworks?
The latest annual turnover of Ginkgo Bioworks is USD 227.04M
What is the latest annual profit for Ginkgo Bioworks?
The latest annual profit of Ginkgo Bioworks is USD -547.03M
What is the registered address of Ginkgo Bioworks?
The registered address for Ginkgo Bioworks is CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
What is the Ginkgo Bioworks website address?
The website address for Ginkgo Bioworks is www.ginkgobioworks.com
Which industry sector does Ginkgo Bioworks operate in?
Ginkgo Bioworks operates in the BLANK CHECKS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
FRGEForge Global Holdings Inc
US$ 11.83
(22.86%)
1.03M
SKILSkillsoft Corp
US$ 21.26
(21.83%)
65.02k
YSGYatsen Holding Limited
US$ 4.1699
(13.31%)
191.53k
ANROAlto Neuroscience Inc
US$ 2.35
(12.98%)
361.74k
RDWRedwire Corporation
US$ 10.16
(11.89%)
1.7M
XINXinyuan Real Estate Co Ltd
US$ 1.62
(-37.69%)
106.38k
SWZTotal Return Securities Fund
US$ 6.415
(-31.61%)
303.13k
BWBabcock and Wilcox Enterprises Inc
US$ 0.3557
(-13.89%)
2.9M
EAFGrafTech International Ltd
US$ 0.63
(-10.19%)
1.24M
TLYSTillys Inc
US$ 1.61
(-9.55%)
69.67k
FFord Motor Company
US$ 9.455
(-2.63%)
125.44M
BACBank of America Corporation
US$ 37.99
(3.60%)
84.68M
NUNu Holdings Ltd
US$ 10.8475
(1.85%)
52.95M
PFEPfizer Inc
US$ 22.44
(1.45%)
51.81M
HPEHewlett Packard Enterprise Co
US$ 15.01
(5.11%)
48.67M

DNA Discussion

View Posts
Monksdream Monksdream 1 week ago
DNA, new 52 week low
👍️0
Monksdream Monksdream 2 months ago
DNA 10Q due TUEsday 2/25
👍️0
Monksdream Monksdream 2 months ago
DNA still climbing
👍️ 1
Monksdream Monksdream 2 months ago
DNA
👍️0
ItsMyOption ItsMyOption 3 months ago
DNA just hit over sold area $8.70 that is .22 before the 1:40 R/S should go back up $11.00 soon
👍️0
Monksdream Monksdream 4 months ago
DNA under $10
👍️0
Monksdream Monksdream 4 months ago
DNA, 10 day hourly
👍️ 1
PonkenPlonken PonkenPlonken 4 months ago
cheap
👍️0
Monksdream Monksdream 6 months ago
DNA under $10
👍️0
Monksdream Monksdream 7 months ago
DNA 10 day hourly post reverse split
👍️0
hwang_jini hwang_jini 7 months ago
Cascade (Gates) top holder
👍️0
Monksdream Monksdream 7 months ago
DNA new. 52 w eek low
👍️0
Monksdream Monksdream 7 months ago
DNA new 52/week low
👍️0
Monksdream Monksdream 7 months ago
DNA new 52 week low
👍️0
Monksdream Monksdream 8 months ago
DNA new 52 week low
👍️0
ItsMyOption ItsMyOption 8 months ago
even after 1:40 R/S DNA still has too many shares outstanding and corporate insiders have poorly mismanaged the company.
Ginkgo Bioworks needs complete restructure and less corporate greed. Some of their founders sell shares daily as they where gifted too many.
I stopped buying long ago and waiting to see if management can get their act together - they all deserve a pay cut!
👍️ 1
Monksdream Monksdream 8 months ago
DNA new 52 low
👍️0
Dingbatt Dingbatt 8 months ago
Interesting stock bought a few for tracking
To see what the crawdads do
👍️0
ItsMyOption ItsMyOption 8 months ago
poor management as they falsely pumped this stock now passing R/S effective Aug. 20
They also know they committed fraud and had to pass = 2. Officer Exculpation Proposal

Item 2 was to approve Article VIII of the Company’s Amended and Restated Certificate of Incorporation to permit officer exculpation (the “Officer Exculpation Proposal”), designated to be voted upon by the holders of Class A common stock and Class B common stock, voting together as a single class. The results of the vote were as follows:

exculpation
noun
a defense of some offensive behavior or some failure to keep a promise etc.
his transparent self-justification was unacceptable
the act of freeing from guilt or blame
👍️0
hwang_jini hwang_jini 8 months ago
bio scam….

https://www.prnewswire.com/news-releases/ginkgo-bioworks-to-hold-special-meeting-of-shareholders-302210173.html
👍️0
Acme Investments Acme Investments 10 months ago
Sometimes I wonder if big names get kickbacks in exchange for their names being used??
👍️0
Acme Investments Acme Investments 10 months ago
Cathy led her sheep 🐑 to slaughter!! Worst performing IPO I've ever seen!!
👍️ 1
Acme Investments Acme Investments 10 months ago
😂😂😂😂😂😂😂
👍️0
trade2brich trade2brich 10 months ago
ARK dumped all holdings. I am out. Cut my losses.
👍️0
Monksdream Monksdream 10 months ago
It will reverse split because there is no choice
👍️0
JohnnyBlaze JohnnyBlaze 10 months ago
Average down or cut losses?
👍️0
Monksdream Monksdream 10 months ago
DNA new 52 week low
👍️0
Acme Investments Acme Investments 10 months ago
Timber!!
👍️0
JohnnyBlaze JohnnyBlaze 10 months ago
Bought a few
👍️0
Acme Investments Acme Investments 10 months ago
R/S will be announced without warning!! Proceed with caution!!
👍️ 1
ItsMyOption ItsMyOption 10 months ago
Yes, new low and very unhappy with DNA management. They were too slow to start restructuring and they still have one of the founders selling stock daily - what does he know?
👍️0
Monksdream Monksdream 10 months ago
DNA new 52 week low
👍️0
Stump Jumper Stump Jumper 10 months ago
I appreciate the response and opinion. I would like to think we would get a small bounce upward from here before a possible RS....
👍️0
philaya philaya 10 months ago
Got in low...
Bounce ready.
👍️0
ItsMyOption ItsMyOption 10 months ago
I feel we are close to bottom possible around.50 as lots of shorts took this down fast. We know DNA is in restructuring mode, which they should have done a long time ago. We still have one of their founders selling shares daily which should be in their ethic guidance as he most likely has inside info on R/S soon.

Long term I am positive but unhappy with management.
👍️0
Stump Jumper Stump Jumper 11 months ago
Is this the bottom?
👍️0
Acme Investments Acme Investments 11 months ago
Acknowledge Me!! Lol 😂
👍️0
wiredawg wiredawg 11 months ago
Yep, yet another SPAC born public company that's in the toilet, I fore see a reverse announcement coming very soon, given they've received a listing standard Notice form the NYSE...
👍️0
Monksdream Monksdream 11 months ago
DNA new 52 week low
👍️0
Acme Investments Acme Investments 11 months ago
I'll take that as a no!! Lol 😂 The Cathy curse continues!!
👍️0
Acme Investments Acme Investments 11 months ago
Still happy??
👍️0
ItsMyOption ItsMyOption 11 months ago
Why DNA will keep going down is all the insider selling from page 43 of last finacials: Austin has been selling shares daily so it is founders driving the price below SEC requirements of min of $1.00
Ginkgo’s Founders currently own nearly 20% of the outstanding shares of Ginkgo, the vast majority of which are in Class B shares
? Class B shares are not freely tradable (must be converted to Class A) and are often not shown on automated data services
? As such, these aggregation services (such as Bloomberg or Yahoo) can be unhelpful in determining actual holdings of certain investors, including
our Founders, who may hold different classes of shares which may not be included

Founder sales through April 29, 2024 relative to total holdings(1)
Mandatory Sell-to-Cover(2) 10b5-1 plan
Shares sold
(in millions) % of holdings
Shares sold
(in millions) % of holdings
Jason (CEO) 12.3 11.3% 10.4 9.6%
Reshma (COO) 12.3 11.4% 1.9 1.8%
Barry (CTO) 12.3 11.2% 1.9 1.7%
Austin 12.3 11.3% 0.9 0.8
👍️0
Acme Investments Acme Investments 11 months ago
Hope you took profits!! They just wanted to burn the shorts!!
👍️0
Acme Investments Acme Investments 11 months ago
That's a lot of risk for 30%......Eventually you'll get snake eyes!!
👍️0
trade2brich trade2brich 11 months ago
Bought at .70….up 30%
👍️0
Acme Investments Acme Investments 11 months ago
Don't know if you noticed but Cathy has lost her MOJO and her investors a lot of money!! Proceed with caution ⚠!!
👍️0
trade2brich trade2brich 11 months ago
ARK bought 12 million shares on Friday
👍️0
Acme Investments Acme Investments 11 months ago
Ark is like the cattle whisperer!! Slaughter awaits!!
👍️0
Monksdream Monksdream 12 months ago
DNA new 52 week low
👍️0
Monksdream Monksdream 12 months ago
Aren’t you the smart one

👍️0